|
Biological innovation is a key component for developing our economy.
It is indisputable that the advances made in biotechnology during
the past few decades can benefit New Zealand's economy.
New Zealand's economy is based on agriculture and agricultural
innovation. Continuous improvement is the only way to maintain and
protect the economic position of New Zealand's primary industries.
As a result ViaLactia has released its first products: genotyping
tests for dairy cattle to facilitate traditional breeding and selection.
ViaLactia endorses the conclusions of the 2002
Royal Commission on Genetic Modification which is leading to
the creation of the most rigorous regulatory regime in the world
for certain biotechnologies.
ViaLactia's research focus is on CISGENIC® applications of
genome information. Improvements to dairy stock and pasture will
be made by moving genes within species using marker-assisted
traditional breeding or more advanced techniques. This is in contrast
to transgenic approaches, where genes are moved between species
using only high-tech methods.
|
